CLINICAL TRIALS

Phase III clinical trials for Therapy-07

The Triple Hair team is starting a Phase III clinical trial in Canada for TH-07, our patented topical treatment for hair loss. The study will evaluate how well TH-07 improves hair density compared with a gold-standard medication and a placebo.

We are currently looking for men experiencing hair loss to participate in this clinical study.

Do you meet the criteria below?  Apply today to help bring an innovative product to market that will change the lives of millions of people.

THE PHASE III
CLINICAL TRIALS
WILL EVALUATE A
6-MONTH TREATMENT

Eligibility criteria

MALE
BETWEEN 18 AND 49 YEARS OLD
CANADIAN
YOU DIDN'T USE ANY INVESTIGATIONAL OR MARKETED DRUG (I.E. MINOXIDIL, ...) IN THE LAST 90 DAYS OR HAD A SURGICAL TREATMENT FOR HAIR LOSS.
WE'RE LOOKING FOR PATIENTS WHOSE DEGREE OF BALDNESS RANKS BETWEEN 3 VERTEX AND 5 ON THE NORWOOD SCALE.
NORWOOD SCALE

Apply

Participants may benefit from using a closely monitored investigational treatment while contribute to advances in hair loss care. Our clinical trial will be supervised by our experienced staff, who follow rigorous protocols and will be pleased to answer any question you may have. All  eligible candidates will be contacted to explain the process before the trial begins.

 

Click NOW on the nearest clinic listed below and complete a short eligibility questionnaire.

 

Dr. Braun Site (Vancouver)

 

Dr. Taher Site (Edmonton)

 

Dr. Vance Elliott Site (Edmonton)

 

Dr. Martin LeBlanc Site (Moncton)

 

Dr. Gilles Pinette Site (Winnipeg)